Medicare Enrolled
Dr. Todd Maltese, D.O.
Neurology · Ronkonkoma, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Maltese from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Maltese?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Maltese
Dr. Todd Maltese is a neurology specialist in Ronkonkoma, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. Maltese performed 22,121 Medicare services across 1,228 unique beneficiaries.
Between the years covered by Open Payments, Dr. Maltese received a total of $50,950 from 80 pharmaceutical and/or device companies across 1047 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Maltese is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 4% volume in NY
$50,950 industry payments
Medicare Practice Summary
Medicare Utilization ↗22,121
Medicare services
Top 4% in NY for neurology
1,228
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,229 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
15,900 | $5 | $8 |
| Bupivacaine injection, 0.5 mg An injection of bupivacaine, a local anesthetic, administered in a dose of 0.5 mg. |
3,326 | $0 | $1 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
898 | $81 | $150 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
338 | $36 | $150 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 231 | $53 | $300 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
230 | $68 | $300 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
209 | $93 | $200 |
| Facial nerve injection with anesthetic and/or steroid An injection of an anesthetic agent and/or steroid into the facial nerve. This procedure delivers medication directly to the nerve. |
191 | $133 | $350 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
177 | $115 | $210 |
| New patient office visit, complex (60-74 min) | 114 | $203 | $370 |
| Suprascapular nerve injection An injection of anesthetic and/or steroid medication into the suprascapular nerve in the shoulder area. |
106 | $104 | $300 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
80 | $162 | $300 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
77 | $427 | $788 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
74 | $161 | $279 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
55 | $119 | $275 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
52 | $196 | $425 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
49 | $229 | $475 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
14 | $106 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$50,950
Total received (2018-2024)
Avg $7,279/year across 7 years
Top 11% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
80
Companies
1,047
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$28,961 (56.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,989 (43.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,285
2023
$9,183
2022
$10,633
2021
$8,560
2020
$3,127
2019
$5,057
2018
$11,104
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$524
SCILEX PHARMACEUTICALS INC.
$369
HARMONY BIOSCIENCES LLC
$354
Teva Pharmaceuticals USA, Inc.
$337
PFIZER INC.
$211
JAZZ PHARMACEUTICALS INC.
$207
UCB, Inc.
$141
Lundbeck LLC
$134
Lilly USA, LLC
$118
ARGENX US, INC.
$108
Amneal Pharmaceuticals LLC
$100
Azurity Pharmaceuticals, Inc.
$80
Medtronic, Inc.
$77
Neurocrine Biosciences, Inc.
$66
Acorda Therapeutics, Inc
$59
Axsome Therapeutics, Inc.
$57
Alexion Pharmaceuticals, Inc.
$53
Kyowa Kirin, Inc.
$50
IDORSIA PHARMACEUTICALS US INC
$49
Biogen, Inc.
$47
Harmony Biosciences Llc
$40
EMD Serono, Inc.
$38
MITSUBISHI TANABE PHARMA AMERICA, INC.
$26
Supernus Pharmaceuticals, Inc.
$24
ZOLL Respicardia, Inc.
$15
Top 3 companies account for 38.0% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$14,345
Supernus Pharmaceuticals, Inc.
$9,350
AbbVie Inc.
$4,822
Teva Pharmaceuticals USA, Inc.
$2,682
Allergan, Inc.
$1,705
Biogen, Inc.
$1,470
UCB, Inc.
$1,466
Harmony Biosciences LLC
$1,074
LivaNova USA, Inc.
$1,053
JAZZ PHARMACEUTICALS INC.
$728
GENZYME CORPORATION
$678
Novartis Pharmaceuticals Corporation
$669
Amgen Inc.
$633
Acorda Therapeutics, Inc
$619
Lundbeck LLC
$618
PFIZER INC.
$610
Lilly USA, LLC
$564
Sunovion Pharmaceuticals Inc.
$548
SCILEX PHARMACEUTICALS INC.
$541
HARMONY BIOSCIENCES LLC
$538
Amneal Pharmaceuticals LLC
$514
EMD Serono, Inc.
$432
SK Life Science, Inc.
$425
Biohaven Pharmaceutical Holding Company Ltd.
$399
Axsome Therapeutics, Inc.
$281
Neurocrine Biosciences, Inc.
$259
IDORSIA PHARMACEUTICALS US INC
$200
Scilex Pharmaceuticals Inc.
$184
Merck Sharp & Dohme LLC
$181
Assertio Therapeutics, Inc.
$178
UPSHER-SMITH LABORATORIES LLC
$171
Abbott Laboratories
$168
Biohaven Pharmaceuticals, Inc.
$153
Allergan Inc.
$148
Medtronic USA, Inc.
$145
Genentech USA, Inc.
$140
ARBOR PHARMACEUTICALS, INC.
$128
Promius Pharma LLC
$123
Alexion Pharmaceuticals, Inc.
$117
Jazz Pharmaceuticals Inc.
$114
Egalet US Inc
$111
ARGENX US, INC.
$108
Almatica Pharma LLC
$104
Azurity Pharmaceuticals, Inc.
$97
Medtronic, Inc.
$93
Upsher-Smith Laboratories LLC
$80
Celgene Corporation
$80
Inspire Medical Systems, Inc.
$74
Bausch Health US, LLC
$72
Horizon Therapeutics plc
$70
Currax Pharmaceuticals LLC
$65
E.R. Squibb & Sons, L.L.C.
$60
MITSUBISHI TANABE PHARMA AMERICA, INC.
$55
Grifols USA, LLC
$55
Impax Laboratories, Inc.
$54
Kyowa Kirin, Inc.
$50
Arbor Pharmaceuticals, Inc.
$49
Neuronetics, Inc.
$49
Harmony Biosciences Llc
$40
Avanir Pharmaceuticals, Inc.
$32
IMPEL PHARMACEUTICALS INC.
$30
Averitas Pharma Inc.
$27
Neurelis, Inc.
$26
Zyla Life Sciences
$24
Boston Scientific Corporation
$24
Forte Bio-Pharma LLC
$23
US WorldMeds, LLC
$20
GRT US Holding, Inc.
$20
Bayer HealthCare Pharmaceuticals Inc.
$19
BANNER LIFE SCIENCES, LLC
$18
Merck Sharp & Dohme Corporation
$18
Collegium Pharmaceutical, Inc.
$17
ASSERTIO THERAPEUTICS, Inc.
$16
Alfasigma USA, Inc.
$16
GE HEALTHCARE
$16
Horizon Pharma plc
$15
ZOLL Respicardia, Inc.
$15
GE Healthcare
$13
Vertical Pharmaceuticals, LLC
$12
AstraZeneca Pharmaceuticals LP
$12
Top 3 companies account for 56.0% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · CAMBIA · COMIRNATY · CONTRAVE · CREXONT · Cambia · Cenobamate · DUEXIS · EMGALITY · GILENYA · GRALISE · Gamunex-C · Gralise · HORIZANT · Horizant · INBRIJA · INGREZZA · INSPIRE · INTELLIS · KESIMPTA · LEMTRADA · LILETTA · LINZESS · LORZONE · LYRICA · MAVENCLAD · MIGRANAL · MOVANTIK · Mavenclad · NALOCET · NAPRELAN · NEUROSTAR TMS THERAPY · NEUROSTAR TMS THERAPY SYSTEM · NORTHERA · NUEDEXTA · NURTEC ODT · Neupro · Nourianz · OCREVUS · ONGENTYS 50MG CAPSULES 30 · ONZETRA XSAIL · Ongentys · PAXLOVID · PERCEPT PC BRAINSENSE · Proclaim Family of SCS IPGs · QELBREE · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QULIPTA · QUTENZA · QUVIVIQ · Qelbree · Qutenza · RADICAVA · RYTARY · Rebif · Reveal LINQ · SOLIRIS · SPRIX · SUNOSI · Sunosi · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VERCISE · VIMOVO · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XCOPRI · XTAMPZA · XYREM · XYWAV · Xadago · Xyrem · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · ZOMIG · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace SymTouch Sumatriptan Injection · Zipsor · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (57%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Neurologists within 10 mi
157
Per 100K population
10.3
County median income
$128,329
Nearest hospital
ST CATHERINE OF SIENA HOSPITAL
5.8 mi
5.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Maltese is a mixed practice specialist, with above-average Medicare volume (top 4% in NY), with speaking/promotional industry engagement in the top 11% of NY peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Maltese experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Maltese performed 15,900 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Maltese receive payments from pharmaceutical companies?
Yes. Dr. Maltese received a total of $50,950 from 80 companies across 1,047 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Maltese's costs compare to other neurologists in Ronkonkoma?
Dr. Maltese's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Maltese) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Ronkonkoma
Browse neurologists in Ronkonkoma ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology